Global Cancer Oncology Testing Supply, Demand and Key Producers, 2023-2029

February 2023 | 111 pages | ID: GAA429DEE9CEEN
GlobalInfoResearch

Abstracts

The global Cancer Oncology Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Cancer Oncology Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer Oncology Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Oncology Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cancer Oncology Testing total market, 2018-2029, (USD Million)

Global Cancer Oncology Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Cancer Oncology Testing total market, key domestic companies and share, (USD Million)

Global Cancer Oncology Testing revenue by player and market share 2018-2023, (USD Million)

Global Cancer Oncology Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Cancer Oncology Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Cancer Oncology Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Oncology Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cancer Oncology Testing Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Cancer Oncology Testing Market, Segmentation by Type

• Fluorescence In Situ Hybridization
• Polymerase Chain Reaction
• Microarray Technology
• Serum Proteomics
• Nucleic Acid Sequencing

Global Cancer Oncology Testing Market, Segmentation by Application

• Hospitals
• Speciality Clinics
• Research Institutes
• Diagnostics Laboratories
• Biopharmaceutical Companies

Companies Profiled:

• Devyser
• Agendia
• Illumina
• Personal Genome Diagnostics
• Veracyte
• Pacific Biosciences of California
• Qiagen
• Agilent Technologies
• Natera
• Bio Rad Laboratories
• Myriad Genetics

Key Questions Answered

1. How big is the global Cancer Oncology Testing market?

2. What is the demand of the global Cancer Oncology Testing market?

3. What is the year over year growth of the global Cancer Oncology Testing market?

4. What is the total value of the global Cancer Oncology Testing market?

5. Who are the major players in the global Cancer Oncology Testing market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Cancer Oncology Testing Introduction
1.2 World Cancer Oncology Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cancer Oncology Testing Total Market by Region (by Headquarter Location)
  1.3.1 World Cancer Oncology Testing Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Cancer Oncology Testing Market Size (2018-2029)
  1.3.3 China Cancer Oncology Testing Market Size (2018-2029)
  1.3.4 Europe Cancer Oncology Testing Market Size (2018-2029)
  1.3.5 Japan Cancer Oncology Testing Market Size (2018-2029)
  1.3.6 South Korea Cancer Oncology Testing Market Size (2018-2029)
  1.3.7 ASEAN Cancer Oncology Testing Market Size (2018-2029)
  1.3.8 India Cancer Oncology Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Cancer Oncology Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Cancer Oncology Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Cancer Oncology Testing Consumption Value (2018-2029)
2.2 World Cancer Oncology Testing Consumption Value by Region
  2.2.1 World Cancer Oncology Testing Consumption Value by Region (2018-2023)
  2.2.2 World Cancer Oncology Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Cancer Oncology Testing Consumption Value (2018-2029)
2.4 China Cancer Oncology Testing Consumption Value (2018-2029)
2.5 Europe Cancer Oncology Testing Consumption Value (2018-2029)
2.6 Japan Cancer Oncology Testing Consumption Value (2018-2029)
2.7 South Korea Cancer Oncology Testing Consumption Value (2018-2029)
2.8 ASEAN Cancer Oncology Testing Consumption Value (2018-2029)
2.9 India Cancer Oncology Testing Consumption Value (2018-2029)

3 WORLD CANCER ONCOLOGY TESTING COMPANIES COMPETITIVE ANALYSIS

3.1 World Cancer Oncology Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Cancer Oncology Testing Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Cancer Oncology Testing in 2022
  3.2.3 Global Concentration Ratios (CR8) for Cancer Oncology Testing in 2022
3.3 Cancer Oncology Testing Company Evaluation Quadrant
3.4 Cancer Oncology Testing Market: Overall Company Footprint Analysis
  3.4.1 Cancer Oncology Testing Market: Region Footprint
  3.4.2 Cancer Oncology Testing Market: Company Product Type Footprint
  3.4.3 Cancer Oncology Testing Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Cancer Oncology Testing Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Cancer Oncology Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Cancer Oncology Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cancer Oncology Testing Consumption Value Comparison
  4.2.1 United States VS China: Cancer Oncology Testing Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Cancer Oncology Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cancer Oncology Testing Companies and Market Share, 2018-2023
  4.3.1 United States Based Cancer Oncology Testing Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Cancer Oncology Testing Revenue, (2018-2023)
4.4 China Based Companies Cancer Oncology Testing Revenue and Market Share, 2018-2023
  4.4.1 China Based Cancer Oncology Testing Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Cancer Oncology Testing Revenue, (2018-2023)
4.5 Rest of World Based Cancer Oncology Testing Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Cancer Oncology Testing Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Cancer Oncology Testing Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Cancer Oncology Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Fluorescence In Situ Hybridization
  5.2.2 Polymerase Chain Reaction
  5.2.3 Microarray Technology
  5.2.4 Serum Proteomics
  5.2.5 Nucleic Acid Sequencing
5.3 Market Segment by Type
  5.3.1 World Cancer Oncology Testing Market Size by Type (2018-2023)
  5.3.2 World Cancer Oncology Testing Market Size by Type (2024-2029)
  5.3.3 World Cancer Oncology Testing Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Cancer Oncology Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Speciality Clinics
  6.2.3 Research Institutes
  6.2.4 Diagnostics Laboratories
  6.2.5 Diagnostics Laboratories
6.3 Market Segment by Application
  6.3.1 World Cancer Oncology Testing Market Size by Application (2018-2023)
  6.3.2 World Cancer Oncology Testing Market Size by Application (2024-2029)
  6.3.3 World Cancer Oncology Testing Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Devyser
  7.1.1 Devyser Details
  7.1.2 Devyser Major Business
  7.1.3 Devyser Cancer Oncology Testing Product and Services
  7.1.4 Devyser Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Devyser Recent Developments/Updates
  7.1.6 Devyser Competitive Strengths & Weaknesses
7.2 Agendia
  7.2.1 Agendia Details
  7.2.2 Agendia Major Business
  7.2.3 Agendia Cancer Oncology Testing Product and Services
  7.2.4 Agendia Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Agendia Recent Developments/Updates
  7.2.6 Agendia Competitive Strengths & Weaknesses
7.3 Illumina
  7.3.1 Illumina Details
  7.3.2 Illumina Major Business
  7.3.3 Illumina Cancer Oncology Testing Product and Services
  7.3.4 Illumina Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Illumina Recent Developments/Updates
  7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Personal Genome Diagnostics
  7.4.1 Personal Genome Diagnostics Details
  7.4.2 Personal Genome Diagnostics Major Business
  7.4.3 Personal Genome Diagnostics Cancer Oncology Testing Product and Services
  7.4.4 Personal Genome Diagnostics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Personal Genome Diagnostics Recent Developments/Updates
  7.4.6 Personal Genome Diagnostics Competitive Strengths & Weaknesses
7.5 Veracyte
  7.5.1 Veracyte Details
  7.5.2 Veracyte Major Business
  7.5.3 Veracyte Cancer Oncology Testing Product and Services
  7.5.4 Veracyte Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Veracyte Recent Developments/Updates
  7.5.6 Veracyte Competitive Strengths & Weaknesses
7.6 Pacific Biosciences of California
  7.6.1 Pacific Biosciences of California Details
  7.6.2 Pacific Biosciences of California Major Business
  7.6.3 Pacific Biosciences of California Cancer Oncology Testing Product and Services
  7.6.4 Pacific Biosciences of California Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Pacific Biosciences of California Recent Developments/Updates
  7.6.6 Pacific Biosciences of California Competitive Strengths & Weaknesses
7.7 Qiagen
  7.7.1 Qiagen Details
  7.7.2 Qiagen Major Business
  7.7.3 Qiagen Cancer Oncology Testing Product and Services
  7.7.4 Qiagen Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Qiagen Recent Developments/Updates
  7.7.6 Qiagen Competitive Strengths & Weaknesses
7.8 Agilent Technologies
  7.8.1 Agilent Technologies Details
  7.8.2 Agilent Technologies Major Business
  7.8.3 Agilent Technologies Cancer Oncology Testing Product and Services
  7.8.4 Agilent Technologies Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Agilent Technologies Recent Developments/Updates
  7.8.6 Agilent Technologies Competitive Strengths & Weaknesses
7.9 Natera
  7.9.1 Natera Details
  7.9.2 Natera Major Business
  7.9.3 Natera Cancer Oncology Testing Product and Services
  7.9.4 Natera Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Natera Recent Developments/Updates
  7.9.6 Natera Competitive Strengths & Weaknesses
7.10 Bio Rad Laboratories
  7.10.1 Bio Rad Laboratories Details
  7.10.2 Bio Rad Laboratories Major Business
  7.10.3 Bio Rad Laboratories Cancer Oncology Testing Product and Services
  7.10.4 Bio Rad Laboratories Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Bio Rad Laboratories Recent Developments/Updates
  7.10.6 Bio Rad Laboratories Competitive Strengths & Weaknesses
7.11 Myriad Genetics
  7.11.1 Myriad Genetics Details
  7.11.2 Myriad Genetics Major Business
  7.11.3 Myriad Genetics Cancer Oncology Testing Product and Services
  7.11.4 Myriad Genetics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Myriad Genetics Recent Developments/Updates
  7.11.6 Myriad Genetics Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Cancer Oncology Testing Industry Chain
8.2 Cancer Oncology Testing Upstream Analysis
8.3 Cancer Oncology Testing Midstream Analysis
8.4 Cancer Oncology Testing Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Cancer Oncology Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cancer Oncology Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cancer Oncology Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cancer Oncology Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cancer Oncology Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cancer Oncology Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cancer Oncology Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cancer Oncology Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cancer Oncology Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cancer Oncology Testing Players in 2022
Table 12. World Cancer Oncology Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cancer Oncology Testing Company Evaluation Quadrant
Table 14. Head Office of Key Cancer Oncology Testing Player
Table 15. Cancer Oncology Testing Market: Company Product Type Footprint
Table 16. Cancer Oncology Testing Market: Company Product Application Footprint
Table 17. Cancer Oncology Testing Mergers & Acquisitions Activity
Table 18. United States VS China Cancer Oncology Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cancer Oncology Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cancer Oncology Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cancer Oncology Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cancer Oncology Testing Revenue Market Share (2018-2023)
Table 23. China Based Cancer Oncology Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cancer Oncology Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cancer Oncology Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cancer Oncology Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cancer Oncology Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cancer Oncology Testing Revenue Market Share (2018-2023)
Table 29. World Cancer Oncology Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cancer Oncology Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cancer Oncology Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cancer Oncology Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cancer Oncology Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cancer Oncology Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Devyser Basic Information, Area Served and Competitors
Table 36. Devyser Major Business
Table 37. Devyser Cancer Oncology Testing Product and Services
Table 38. Devyser Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Devyser Recent Developments/Updates
Table 40. Devyser Competitive Strengths & Weaknesses
Table 41. Agendia Basic Information, Area Served and Competitors
Table 42. Agendia Major Business
Table 43. Agendia Cancer Oncology Testing Product and Services
Table 44. Agendia Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Agendia Recent Developments/Updates
Table 46. Agendia Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Cancer Oncology Testing Product and Services
Table 50. Illumina Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Personal Genome Diagnostics Basic Information, Area Served and Competitors
Table 54. Personal Genome Diagnostics Major Business
Table 55. Personal Genome Diagnostics Cancer Oncology Testing Product and Services
Table 56. Personal Genome Diagnostics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Personal Genome Diagnostics Recent Developments/Updates
Table 58. Personal Genome Diagnostics Competitive Strengths & Weaknesses
Table 59. Veracyte Basic Information, Area Served and Competitors
Table 60. Veracyte Major Business
Table 61. Veracyte Cancer Oncology Testing Product and Services
Table 62. Veracyte Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Veracyte Recent Developments/Updates
Table 64. Veracyte Competitive Strengths & Weaknesses
Table 65. Pacific Biosciences of California Basic Information, Area Served and Competitors
Table 66. Pacific Biosciences of California Major Business
Table 67. Pacific Biosciences of California Cancer Oncology Testing Product and Services
Table 68. Pacific Biosciences of California Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pacific Biosciences of California Recent Developments/Updates
Table 70. Pacific Biosciences of California Competitive Strengths & Weaknesses
Table 71. Qiagen Basic Information, Area Served and Competitors
Table 72. Qiagen Major Business
Table 73. Qiagen Cancer Oncology Testing Product and Services
Table 74. Qiagen Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Qiagen Recent Developments/Updates
Table 76. Qiagen Competitive Strengths & Weaknesses
Table 77. Agilent Technologies Basic Information, Area Served and Competitors
Table 78. Agilent Technologies Major Business
Table 79. Agilent Technologies Cancer Oncology Testing Product and Services
Table 80. Agilent Technologies Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Agilent Technologies Recent Developments/Updates
Table 82. Agilent Technologies Competitive Strengths & Weaknesses
Table 83. Natera Basic Information, Area Served and Competitors
Table 84. Natera Major Business
Table 85. Natera Cancer Oncology Testing Product and Services
Table 86. Natera Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Natera Recent Developments/Updates
Table 88. Natera Competitive Strengths & Weaknesses
Table 89. Bio Rad Laboratories Basic Information, Area Served and Competitors
Table 90. Bio Rad Laboratories Major Business
Table 91. Bio Rad Laboratories Cancer Oncology Testing Product and Services
Table 92. Bio Rad Laboratories Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Bio Rad Laboratories Recent Developments/Updates
Table 94. Myriad Genetics Basic Information, Area Served and Competitors
Table 95. Myriad Genetics Major Business
Table 96. Myriad Genetics Cancer Oncology Testing Product and Services
Table 97. Myriad Genetics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Cancer Oncology Testing Upstream (Raw Materials)
Table 99. Cancer Oncology Testing Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Oncology Testing Picture
Figure 2. World Cancer Oncology Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cancer Oncology Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cancer Oncology Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cancer Oncology Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cancer Oncology Testing Revenue (2018-2029) & (USD Million)
Figure 13. Cancer Oncology Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cancer Oncology Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cancer Oncology Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cancer Oncology Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Oncology Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Oncology Testing Markets in 2022
Figure 27. United States VS China: Cancer Oncology Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cancer Oncology Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cancer Oncology Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cancer Oncology Testing Market Size Market Share by Type in 2022
Figure 31. Fluorescence In Situ Hybridization
Figure 32. Polymerase Chain Reaction
Figure 33. Microarray Technology
Figure 34. Serum Proteomics
Figure 35. Nucleic Acid Sequencing
Figure 36. World Cancer Oncology Testing Market Size Market Share by Type (2018-2029)
Figure 37. World Cancer Oncology Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Cancer Oncology Testing Market Size Market Share by Application in 2022
Figure 39. Hospitals
Figure 40. Speciality Clinics
Figure 41. Research Institutes
Figure 42. Diagnostics Laboratories
Figure 43. Biopharmaceutical Companies
Figure 44. Cancer Oncology Testing Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source